Addressing the Palliative Care Needs of Patients with Acute Myeloid Leukemia (AML)

DESCRIPTION

Specialty Compared to Oncology delivered Palliative Care for Patients with Acute Myeloid Leukemia (SCOPE-Leukemia) is a cluster-randomized comparative effectiveness trial of primary palliative care versus specialty palliative care in patients with acute myeloid leukemia (AML) and their caregivers. The goal of the trial is to answer a critical question on how to best address the palliative care needs of patients with AML and their caregivers and provide essential data on how healthcare systems can ensure that optimal palliative care services are available for their patients.

As part of this trial, leukemia clinicians (i.e., physicians and advance practice providers) will attend a three-hour palliative care training focused on the following educational objectives:

  • Understand the unmet palliative care needs of patients with AML.
  • Manage the physical and psychological symptoms experienced by patients with AML.
  • Develop strategies to promote effective coping and enhance illness and prognostic understanding in patients with AML.
  • Promote shared decision-making and strategies to optimize end-of-life care for patients with AML.

* Please Note: This educational course will be offered on multiple occasions to accommodate the schedule of leukemia clinicians participating across multiple institutions. Leukemia clinicians will attend a single educational training that will last 3 hours. There will be at least 10 sessions throughout the duration of this course.

Target Audience

This activity is intended for Physicians, Nurse Practitioners and Physician Assistants in the specialties of Hematology/Oncology and Hospice and Palliative Care.

Learning Objectives

Upon completion of the training course, participants will be able to:

  1. Assess the palliative care needs of hospitalized patients with AML.
  2. Demonstrate effective management of physical and psychological symptoms experienced by patients with AML.
  3. Discuss effective coping and engage in discussions to enhance illness and prognostic understanding in patients with AML.
  4. Discuss end-of-life care preferences for patients with AML and incorporate strategies to optimize care at the end of life for this population.
  5. Demonstrate effective collaboration among MD and APP team members when delivering palliative care to patients with AML.

Additional Information

Provided by: 

Massachusetts General Hospital
Cancer Outcomes Research Education Program (CORE)
Division of Palliative Care and Geriatric Medicine

Oregon Health and Science University
Medicine and Psychiatry

Mass General Brigham

Course summary
Course opens: 
03/11/2022
Course expires: 
07/01/2023
Cost:
$0.00
MA
United States

Areej El-Jawahri, MD - Course Director

Director of BMT Survivorship Program,
Associate Director of the Cancer Outcomes Research and Education Program (CORE),
Massachusetts General Hospital;
Director of Digital Health,
Massachusetts General Hospital Cancer Center;
Associate Professor of Medicine,
Harvard Medical School

In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation (Primary Palliative Care)
American Medical Association (AMA) 

Mass General Brigham designates this live activity for a maximum of 3 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Academy of Physician Assistants (AAPA)
Mass General Brigham has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 3 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.  

Credit Designation (Specialty Palliative Care)
American Medical Association (AMA) 
Mass General Brigham designates this live activity for a maximum of 3.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Academy of Physician Assistants (AAPA)
Mass General Brigham has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 3.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

 
Status
Price
Title
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.

Price

Cost:
$0.00
Please login or register to take this course.

Please select the session you wish to attend, and click 'Enroll'

For questions regarding registration or CME information, please contact Michelle Alley at malley2@partners.org or 857-282-2513.